We are very pleased to announce that Neurosoft Bioelectronics has been selected to participate in the Medlim Fast Track Acceleration Program. This year the program has selected 9 promising startups developing breakthrough technology in the Cardiovascular, Diabetes,...

During the 9th edition of “Les Meilleures startups ” (Best Startups), organized by the Swiss magazine Bilan, Neurosoft Bioelectronics was selected as one of the most promising startups to invest in. This year 31 startups were chosen out of 88 applicants coming from...

We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 5 finalists competing for the Prix Strategis 2021. In the final stage we will have the chance to pitch to the Jury, who will select the winning startup, to be announced on May 12th....

A new study led by Dr. Florian Fallegger (CTO of Neurosoft Bioelectronics) has been recently published in Advanced Science, highlighting the promising potential of our soft technology for the development of neural implants in clinical settings. Neural implants can be...

We are very pleased to announce that Neurosoft Bioelectronics has won the highest stage of Venture Kick and received a final round of funding for a total of 150 000 CHF. The Venture Kick jury has selected our project to receive the final “kick”, supporting us in the...

We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 8 semi-finalist startups competing for the Prix Strategis 2021. The Jury has selected our project out of 111 promising applicants. The next step will be a meeting with students from...

We are happy to announce that Karsten Bagger has joined Neurosoft Bioelectronics as its Chief Business Officer (CBO).Karsten has a MSc in Finance, he previously worked at UBS as an investment strategist and over the past 6 years, he has mainly headed up medtech...

In April our CEO and co-founder Nicolas Vachicouras was selected to represent Neurosoft Bioelectronics as part of the Swiss National Startup Team for Venture Leaders Life Sciences 2020. In November he will have the opportunity to travel to Boston, a major medical hub,...

We are very pleased to announce that Neurosoft Bioelectronics has passed stage 2 of Venture Kick and received a second round of funding of 40 000 CHF. The Venture Kick jury has selected our project to receive the second “kick” and has chosen to support us in further...

During the 2020 >>venture>> award ceremony, Neurosoft Bioelectronics was ranked 2nd in the Health & Nutrition category. We were one of the three finalists (along with Urodea and NextKidney) out of 89 initial applicants in our vertical.The >>venture>> competition...